SLC5A2 and diabetes mellitus: The stimulatory effect of diabetes on thrombocytosis was also prevented by SGLT2 inhibition, suggesting that SGLT2 inhibitors prevent both diabetes-induced monocytosis and thrombocytosis in these mouse models.